LILRB4 and neoplasm: LILRB4 is a well-known marker of monocytic leukemia, and it supports tumor cell infiltration into tissues and inhibits the proliferation and activation of T lymphocytes through a signaling pathway involving APOE–LILRB4–SHP2–uPAR–ARG1 in AML cells [17].